ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,066.00
-0.07%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36175
0.00%
Bitcoin
66,938.79
-0.21%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Terns Pharmaceuticals Inc (TERN)

  7. Terns Pharmaceuticals Inc (TERN) News

TERN

Terns Pharmaceuticals (TERN)

Terns Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TERN
DateTimeSourceHeadlineSymbolCompany
05/17/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics DayNASDAQ:TERNTerns Pharmaceuticals Inc
05/13/20243:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TERNTerns Pharmaceuticals Inc
05/13/20247:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
05/13/20247:05AMGlobeNewswire Inc.Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
05/08/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Announces Leadership ChangesNASDAQ:TERNTerns Pharmaceuticals Inc
05/07/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024NASDAQ:TERNTerns Pharmaceuticals Inc
05/03/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
04/29/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive DifferentiationNASDAQ:TERNTerns Pharmaceuticals Inc
04/10/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
03/14/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
03/11/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid LeukemiaNASDAQ:TERNTerns Pharmaceuticals Inc
03/07/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
03/05/20245:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
02/27/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming March Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
02/15/20245:02PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
02/14/20247:57AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TERNTerns Pharmaceuticals Inc
02/07/20243:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TERNTerns Pharmaceuticals Inc
02/07/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
02/07/20247:05AMGlobeNewswire Inc.Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
02/02/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
01/25/20246:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TERNTerns Pharmaceuticals Inc
01/04/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TERNTerns Pharmaceuticals Inc
01/03/20243:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
11/29/20233:05PMGlobeNewswire Inc.Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology SummitNASDAQ:TERNTerns Pharmaceuticals Inc
11/27/20233:05PMGlobeNewswire Inc.Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive OfficerNASDAQ:TERNTerns Pharmaceuticals Inc
11/14/20237:05AMGlobeNewswire Inc.Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:TERNTerns Pharmaceuticals Inc
11/13/20237:05AMGlobeNewswire Inc.Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023NASDAQ:TERNTerns Pharmaceuticals Inc
11/09/20237:05AMGlobeNewswire Inc.Terns Pharmaceuticals to Participate in Upcoming November Investor ConferencesNASDAQ:TERNTerns Pharmaceuticals Inc
11/03/20233:05PMGlobeNewswire Inc.Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:TERNTerns Pharmaceuticals Inc
11/02/20233:05PMGlobeNewswire Inc.Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of ObesityNASDAQ:TERNTerns Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TERN

Your Recent History

USOTC
CTTH
CTT Pharmaceutical (PK)
TSXV
CHC.H
CHC Student Housing
TSX
9561
Glad Cube
COIN
SDGOGBP
BIT
I06747
Intesa Sanpaolo
COIN
OOKIGBP
Ooki Token
ASX
MMSKOD
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved